Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 79,903 |
|
|||||
| News | - | ||||||
| Day High | 5.2648 | Low High |
|||||
| Day Low | 4.92 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Immix Biopharma Inc | IMMX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.16 | -3.08% | 5.03 | 18:53:37 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 5.21 | 4.92 | 5.2648 | 5.03 | 5.19 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 856 | 79,903 | US$ 5.04 | US$ 403,087 | - | 1.01 - 5.47 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:33:34 | 1 | US$ 5.03 | USD |
Immix Biopharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 99.14M | 19.87M | - | 0 | -8.23M | -0.41 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Immix Biopharma News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMMX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.77 | 5.47 | 4.60 | 5.13 | 236,254 | 0.26 | 5.45% |
| 1 Month | 3.65 | 5.47 | 3.38 | 4.45 | 238,257 | 1.38 | 37.81% |
| 3 Months | 2.63 | 5.47 | 2.3408 | 3.89 | 243,426 | 2.40 | 91.25% |
| 6 Months | 2.09 | 5.47 | 1.55 | 3.27 | 181,481 | 2.94 | 140.67% |
| 1 Year | 1.04 | 5.47 | 1.01 | 2.19 | 470,715 | 3.99 | 383.65% |
| 3 Years | 5.00 | 8.6799 | 0.68 | 4.15 | 1,378,842 | 0.03 | 0.6% |
| 5 Years | 5.00 | 8.6799 | 0.68 | 4.15 | 1,378,842 | 0.03 | 0.6% |
Immix Biopharma Description
| Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation. |
